Parkman Healthcare Partners LLC Xenon Pharmaceuticals Inc. Transaction History

Parkman Healthcare Partners LLC

$708 Million
Q3 2024

A detailed history of Parkman Healthcare Partners LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 191,658 shares of XENE stock, worth $7.34 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

191,658

Previous 209,290 8.42%

Holding current value

$7.34 Million

Previous $8.16 Million 7.59%

% of portfolio

1.06%

Previous 1.2%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.12 - $43.96 $636,867 - $775,102	-17,632 Reduced 8.42%	191,658 $7.54 Million
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $531,135 - $641,025	-14,652 Reduced 6.54%	209,290 $8.16 Million
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $3.02 Million - $3.55 Million	-70,846 Reduced 24.03%	223,942 $9.64 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $2.24 Million - $3.63 Million	78,144 Added 36.07%	294,788 $13.6 Million
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $37,439 - $43,544	-1,096 Reduced 0.5%	216,644 $7.4 Million
Q2 2023 Aug 11, 2023	SELL	$34.84 - $43.54 $2.07 Million - $2.59 Million	-59,543 Reduced 21.47%	217,740 $8.38 Million
Q1 2023 May 12, 2023	BUY	$33.46 - $40.35 $1.4 Million - $1.69 Million	41,792 Added 17.75%	277,283 $9.92 Million
Q4 2022 Feb 13, 2023	BUY	$33.06 - $39.43 $426,275 - $508,410	12,894 Added 5.79%	235,491 $9.29 Million
Q3 2022 Nov 14, 2022	SELL	$30.79 - $39.82 $2.22 Million - $2.87 Million	-71,962 Reduced 24.43%	222,597 $8.04 Million
Q2 2022 Aug 12, 2022	SELL	$25.44 - $35.16 $244,910 - $338,485	-9,627 Reduced 3.16%	294,559 $8.96 Million
Q1 2022 May 13, 2022	SELL	$25.09 - $33.13 $1.41 Million - $1.87 Million	-56,316 Reduced 15.62%	304,186 $9.3 Million
Q4 2021 Feb 11, 2022	BUY	$15.6 - $35.4 $769,002 - $1.75 Million	49,295 Added 15.84%	360,502 $11.3 Million
Q3 2021 Nov 12, 2021	SELL	$14.86 - $19.45 $1.34 Million - $1.75 Million	-90,000 Reduced 22.43%	311,207 $4.76 Million
Q2 2021 Aug 13, 2021	BUY	$16.81 - $20.0 $450,709 - $536,240	26,812 Added 7.16%	401,207 $7.47 Million
Q1 2021 May 14, 2021	BUY	$13.65 - $21.31 $173,436 - $270,764	12,706 Added 3.51%	374,395 $6.7 Million
Q4 2020 Feb 12, 2021	SELL	$9.49 - $16.04 $978,760 - $1.65 Million	-103,136 Reduced 22.19%	361,689 $5.56 Million
Q3 2020 Nov 13, 2020	SELL	$10.82 - $13.35 $1.36 Million - $1.67 Million	-125,442 Reduced 21.25%	464,825 $5.15 Million
Q1 2020 May 15, 2020	BUY	$8.08 - $17.57 $17,840 - $38,794	2,208 Added 0.38%	590,267 $6.69 Million
Q4 2019 Feb 13, 2020	BUY	$8.11 - $14.65 $4.77 Million - $8.62 Million	588,059 New	588,059 $7.71 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account

Parkman Healthcare Partners LLC Xenon Pharmaceuticals Inc. Transaction History